This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

BPH overview

GSK's commitment to research in urology and benign prostatic hyperplasia (BPH) has helped to improve the lives of patients throughout the world, with more than 20 years’ experience of aiding patients and physicians in the management of this disease.

Duodart

dutasteride/tamsulosin

Find out about our products in the Urology portfolio, including prescribing and safety information.

Find out more

Trade marks are owned by or licensed to the GSK group of companies.
©2021 GSK group of companies or its licensor.